AICDA and B-cell chronic lymphocytic leukemia: Using a novel signature discovery method that uses information on both sequence context and mutation distance, we were able to identify three mutational signatures operative in CLL, including two distinct AID processes (c-AID and nc-AID) that represent a greater fraction of mutational activity in mutated IGHV cases, and the ageing-related signature.